US 10604758
Therapeutic oligomers for treating amyloidosis
granted A61KA61K31/685A61K31/713
Quick answer
US patent 10604758 (Therapeutic oligomers for treating amyloidosis) held by ARCTURUS THERAPEUTICS, INC. expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/685, A61K31/713, A61K9/127